EFS and OS for non-CBF aberrant karyotypes in the AML96 trial depending on marker chromosome detection. EFS (A,C,E) and OS curves (B,D,F) are provided for the total AML96 patient group (A, B), the age subgroup ≤60 years (C,D), and the age subgroup >60 years (E,F).